Medicine recalls: how they work and who orders them

A medicine recall is an action taken to remove a medicinal product from the market because it is defective, potentially harmful, or violates regulatory standards. Recalls are a critical component of pharmacovigilance—the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem. Once a medicine is approved and widely used by the public, previously undetected issues can emerge. These can range from manufacturing defects and contamination to labelling errors or the discovery of new safety risks during post-market surveillance. When a recall occurs, it ensures that the affected product is swiftly removed from pharmacy shelves and supply chains to protect public health.

The Levels of a Recall

Regulators generally categorise recalls based on the level of health risk the defective product poses to the public. While terminology can vary slightly by country, many global regulators use a three-tier classification system. A Class I recall is the most serious. It is issued when there is a reasonable probability that using the product will cause severe adverse health consequences or death. A Class II recall involves products that may cause temporary or medically reversible adverse health consequences, or where the probability of serious harm is remote. Class III recalls are the least severe; they involve products that are unlikely to cause adverse health consequences but still violate regulatory standards, such as minor packaging or labelling errors that do not affect the medicine's safety or dosage.

Who Orders a Recall?

The majority of medicine recalls are voluntary. They are typically initiated by the manufacturer, importer, or distributor when they discover a problem with a batch of their product. Regulators strongly encourage companies to report these issues immediately and conduct the recall themselves. However, if a company fails to act appropriately, national regulatory authorities have the power to order a mandatory recall. In the United States, the Food and Drug Administration (FDA) oversees this process. In Europe, the European Medicines Agency (EMA) coordinates recalls with national competent authorities. In South Africa, the South African Health Products Regulatory Authority (SAHPRA) is responsible for ordering or overseeing recalls. SAHPRA has the legal authority to direct manufacturers to remove unsafe medicines from the market and ensure that the Single Exit Price framework accommodates the reimbursement or replacement of returned stock where applicable.

Communicating Recalls to the Public

Effective communication is essential during a recall. When a recall is initiated, the manufacturer and the regulatory authority will issue alerts to healthcare professionals, pharmacies, and the public. Regulators often maintain public databases where consumers can search for recalled products by name or batch number. At the pharmacy level, wholesalers and pharmacists are notified directly to stop dispensing the affected batches and to quarantine their existing stock. Using their dispensing software, pharmacies can often trace which patients received the specific batch of medicine and contact them directly to arrange a replacement. In South Africa, SAHPRA issues formal recall notices through its official channels, providing clear instructions on how healthcare providers and patients should handle the affected products.

Notable Historical Recalls

Several high-profile recalls have heavily influenced modern medicine regulation. One of the most famous examples is the 2004 global withdrawal of rofecoxib, a painkiller marketed under the brand name Vioxx. The manufacturer voluntarily recalled the drug after post-market data revealed an increased risk of cardiovascular events, such as heart attacks and strokes. Another significant event occurred in 2019, when ranitidine, a widely used heartburn medication commonly known as Zantac, was recalled globally. This was triggered by the discovery that ranitidine products contained unacceptable levels of NDMA, a probable human carcinogen, which could increase over time or when exposed to high temperatures. These examples highlight why post-market surveillance is vital, as some risks only become apparent after a medicine has been used by millions of people over several years.

What to Do During a Recall

If a medicine you are taking is recalled, health authorities generally advise against stopping treatment abruptly without first consulting a healthcare professional. The standard guidance is to return the affected medicine to the pharmacy where it was purchased or dispensed for a safe replacement or refund. Patients can identify if their specific medicine is affected by checking the batch number printed on the packaging against the official recall notice. Online tools like HealthSA can help South African patients and healthcare providers verify the registration status of their medicines, ensuring they are dealing with legitimate, SAHPRA-registered products. For official recall notices, consumers should always rely on direct communications from regulators like SAHPRA, the FDA, or the EMA.